Cvs Health (CVS) Cash & Equivalents (2009 - 2026)

Cvs Health's Cash & Equivalents history runs 18 years deep, the most recent figure standing at $9.5 billion for Q1 2026.

• Quarterly Cash & Equivalents fell 5.3% year-over-year to $9.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.5 billion (down 5.3% YoY) and the FY2025 annual result came in at $8.5 billion, down 1.55% from the prior year.
• Cash & Equivalents was $9.5 billion for Q1 2026 at Cvs Health, up from $8.5 billion in the prior quarter.
• Across five years, Cash & Equivalents topped out at $17.2 billion in Q3 2022 and bottomed at $6.9 billion in Q3 2024.
• A 5-year average of $11.0 billion and a median of $10.1 billion in 2025 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2022 — Cash & Equivalents jumped 75.02% — and 2024, when it tumbled 47.29%.
• Cvs Health's Cash & Equivalents stood at $12.9 billion in 2022, then tumbled by 36.69% to $8.2 billion in 2023, then increased by 4.76% to $8.6 billion in 2024, then dropped by 1.55% to $8.5 billion in 2025, then grew by 12.88% to $9.5 billion in 2026.
• Business Quant data shows CVS's Cash & Equivalents at $9.5 billion in Q1 2026, $8.5 billion in Q4 2025, and $9.1 billion in Q3 2025.